Percentages of children with peanut allergy who responded to treatment with the VP250 VIASKIN Peanut patch from DBV Technologies increased from 12 months through 60 months, according to an abstract ...

Food allergy, intolerance, and sensitivity generally differ based on whether or not IgE, a protein the body can make against ...

Early dietary diversity in infants may reduce the risk of food allergies by promoting immune tolerance and gut microbiome ...

Omalizumab (Xolair) injections outperformed oral immunotherapy (OIT) in increasing tolerance among children with multi-food ...

"The effect of formula supplementation spans beyond cow's milk allergy," Bhasin said, citing a prior randomized trial showing ...

Patients with multiple food allergies introduced allergens into their diets after using omalizumab, researchers reported at ...

Obesity worsens asthma severity and responses to medication, yet most doctors fail to address weight management with these ...

Omalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC) ...

SAN DIEGO ‑- Off-the-shelf peanut products used in oral immunotherapy for peanut allergies contain a wide range of protein ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...

Pope Francis suffered two episodes of acute respiratory distress Monday as his prognosis remains "guarded" while at a hospital in Rome, the Vatican announced.

Omalizumab was found to be more effective than multi-allergen oral immunotherapy (OIT) in reducing allergic reactions in patients with 1 or more food allergies, according to results from Stage 2 of ...